跳至主要内容
临床试验/NCT00873015
NCT00873015已完成2 期

Safety and Pharmacokinetic Evaluation of Sodium Nitrite Injection for the Prevention of Post-Subarachnoid Hemorrhage Induced Vasospasm

Hope Pharmaceuticals1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2010年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
19
试验地点
1
主要终点
Mean Plasma Nitrite Concentration (Micromol/L)

研究概览

简要总结

The purpose of the study is to examine the safety of a 14 day infusion of sodium nitrite, and to study the pharmacokinetics of nitrite, during a 14 day infusion in patients with ruptured cerebral aneurysms.

详细描述

Intravenous sodium nitrite has been shown to prevent and to reverse cerebral vasospasm in a primate model of subarachnoid hemorrhage (SAH). This was a Phase IIA dose escalation study of sodium nitrite to determine its safety in patients with aneurysmal SAH and to establish its pharmacokinetics during a 14 day infusion.

Sodium nitrite was delivered intravenously for 14 days in 18 patients with SAH from a ruptured cerebral aneurysm using a dose escalation scheme in three cohorts of 6 patients each (3 nitrite, 3 saline), with a maximum dose of 64 nmol/min/kg. Sodium nitrite blood levels were frequently sampled and measured using mass spectroscopy and blood methemoglobin levels were continuously monitored using a pulse oximeter.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ruptured cerebral aneurysm

排除标准

  • Pregnancy, sickle cell disease, G6PD deficiency, anticoagulant therapy

研究组 & 干预措施

Nitrite

Experimental

Continuous intravenous infusion of Sodium Nitrite

干预措施: Sodium nitrite (Drug)

Vehicle control

Placebo Comparator

Continuous intravenous infusion of saline

干预措施: Saline (Drug)

结局指标

主要结局

Mean Plasma Nitrite Concentration (Micromol/L)

时间窗: multiple time points up to the end of day 14

Samples for pharmacokinetic analysis were collected from subjects treated with sodium nitrite at -15, -5, 0, 10, 30, 60, and 90 minutes after starting nitrite infusion and then at 2, 4, 6, 8, 12, 24, and every 24 hours after starting nitrite infusion. The sample at the time of starting the infusion was considered to be the time 0 sample. On study day 14 additional blood samples were collected at 0, 10, 30, 60, and 90 minutes and at 2, 4, 6, 8, and 12 hours after stopping nitrite infusion. Blood samples were analyzed for nitrite levels using mass spectroscopy.

次要结局

  • Efficacy of 14 Day Infusion of Sodium Nitrite(14 days)
  • Safety of a 14 Day Infusion of Sodium Nitrite(14 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验